Medicare Enrolled

Dr. Douglas Wolf, MD

Gastroenterology · Atlanta, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
5671 PEACHTREE DUNWOODY RD NE, Atlanta, GA 30342
4042579000
In practice since 2005 (20 years)
NPI: 1588649693 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wolf from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wolf? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wolf

Dr. Douglas Wolf is a gastroenterology specialist in Atlanta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Wolf performed 1,573 Medicare services across 218 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wolf received a total of $691,527 from 53 pharmaceutical and/or device companies across 1085 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wolf is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 9% volume in GA $691,527 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,573
Medicare services
Top 9% in GA for gastroenterology
218
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~79 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
1,320 $26 $95
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
76 $83 $392
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
75 $137 $547
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
36 $61 $600
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
36 $136 $793
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
18 $48 $230
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
12 $103 $540
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
85.8% high complexity
4.6% medium
9.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$691,527
Total received (2018-2024)
Avg $98,790/year across 7 years
Top 0% in GA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
1,085
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$568,392 (82.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$115,692 (16.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,443 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$130,119
2023
$89,936
2022
$102,160
2021
$51,439
2020
$54,489
2019
$141,432
2018
$121,953

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$60,829
Janssen Biotech, Inc.
$46,535
Takeda Pharmaceuticals U.S.A., Inc.
$11,920
E.R. Squibb & Sons, L.L.C.
$8,663
Celgene Corporation
$1,003
PFIZER INC.
$163
Lilly USA, LLC
$160
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$138
Ipsen Biopharmaceuticals, Inc
$115
Intercept Pharmaceuticals, Inc.
$77
Celltrion USA Inc.
$76
Merck Sharp & Dohme LLC
$64
ConvaTec Inc.
$54
Madrigal Pharmaceuticals
$52
Sandoz Inc.
$50
Ardelyx, Inc.
$41
AIMMUNE THERAPEUTICS, INC.
$41
Phathom Pharmaceuticals, Inc.
$36
Medtronic, Inc.
$32
Regeneron Healthcare Solutions, Inc.
$26
GENZYME CORPORATION
$22
VIVUS LLC
$21
Top 3 companies account for 91.7% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$108,892
Janssen Scientific Affairs, LLC
$101,842
PFIZER INC.
$82,201
ABBVIE INC.
$80,518
Takeda Pharmaceuticals U.S.A., Inc.
$74,065
E.R. Squibb & Sons, L.L.C.
$72,734
AbbVie Inc.
$51,909
AbbVie, Inc.
$45,985
Eli Lilly and Company
$26,408
Celgene Corporation
$13,007
UCB, Inc.
$10,652
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$9,655
Daiichi Sankyo Inc.
$4,150
Gilead Sciences, Inc.
$2,715
Janssen Research & Development, LLC
$2,327
Lilly USA, LLC
$1,975
Synergy Pharmaceuticals Inc
$278
Merck Sharp & Dohme LLC
$208
Merck Sharp & Dohme Corporation
$190
Intercept Pharmaceuticals, Inc.
$153
Ipsen Biopharmaceuticals, Inc
$115
VIVUS LLC
$113
Allergan Inc.
$112
Regeneron Healthcare Solutions, Inc.
$109
Nestle HealthCare Nutrition Inc.
$109
Sandoz Inc.
$89
INTERCEPT PHARMACEUTICALS, INC.
$80
Ferring Pharmaceuticals Inc.
$80
Celltrion USA Inc.
$76
Ironwood Pharmaceuticals, Inc
$74
GENZYME CORPORATION
$66
AIMMUNE THERAPEUTICS, INC.
$61
ConvaTec Inc.
$54
Madrigal Pharmaceuticals
$52
Romark Laboratories, LC
$46
Ardelyx, Inc.
$41
AMAG Pharmaceuticals, Inc.
$41
Phathom Pharmaceuticals, Inc.
$36
IRONWOOD PHARMACEUTICALS, INC
$34
Allergan, Inc.
$33
Medtronic, Inc.
$32
Amgen Inc.
$26
RedHill Biopharma Inc.
$24
Bayer HealthCare Pharmaceuticals Inc.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Novo Nordisk Inc
$22
Shire North American Group Inc
$18
Prometheus Laboratories Inc.
$17
Exact Sciences Corporation
$16
Organon LLC
$14
Alfasigma USA, Inc.
$13
INTRA-SANA LABORATORIES
$12
Napo Pharmaceuticals Inc
$3
Top 3 companies account for 42.4% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · APRISO · Aemcolo · Alinia Tablets 500mg 30 count bottle · Bylvay · CIMZIA · CLENPIQ · CONVATEC INC. · CREON · CYLTEZO · Cimzia · Cologuard Collection Kit · Creon · DIFICID · DUPIXENT · ENTYVIO · Entyvio · FERAHEME · GATTEX · HUMIRA · HYRIMOZ · Humira · IBSRELA · INJECTAFER · INTERSTIM · IQIRVO · LINZESS · Linzess · MAVYRET · MOTEGRITY · Mavyret · Mytesi · Nexavar · OCALIVA · OMVOH · Ozanimod · Ozempic · QSYMIA · Qsymia · RELTONE 200 MG · RENFLEXIS · RESMETIROM · RINVOQ · SIMPONI · SKYRIZI · STELARA · TREMFYA · TRULANCE · Tremfya · Trulance · UCERIS · UCERIS TABLETS · VEGZELMA · VELSIPITY · VIBERZI · VOQUEZNA · VOWST · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA · ZYMFENTRA · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (82%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for gastroenterology in GA.

Looking for a gastroenterology specialist in Atlanta?
Compare gastroenterologists in the Atlanta area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
231
Per 100K population
21.6
County median income
$91,490
Nearest hospital
SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wolf is a mixed practice specialist, with above-average Medicare volume (top 9% in GA), with speaking/promotional industry engagement in the top 0% of GA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wolf experienced with infliximab infusion (remicade)?
Based on Medicare claims data, Dr. Wolf performed 1,320 infliximab infusion (remicade) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wolf receive payments from pharmaceutical companies?
Yes. Dr. Wolf received a total of $691,527 from 53 companies across 1,085 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wolf's costs compare to other gastroenterologists in Atlanta?
Dr. Wolf's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wolf) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →